Agile Biomedical in China
From our base in Linping District, Hangzhou, we connect UK expertise with partners across China.
A bridge between two research ecosystems
China's biopharmaceutical sector is growing quickly in scale and in openness to international partnership. Our China operation gives Chinese organisations direct access to our UK team's expertise, and gives our UK partners access to research, clinical and manufacturing capacity in China.
The China operation is part of the same team, with the same directors, methods and standards as our UK company.
Services for partners across China
R&D services
Preclinical testing, assay development and drug evaluation through our biopharmaceutical R&D service platform.
Statistics and data
Study design, biostatistics, bioinformatics and data analysis, delivered by our UK specialists.
Training
Research training in study design, data quality and analysis, in person or online.
UK–China partnerships
Connecting Chinese and UK companies, universities and investors for joint research and development.
Our China story so far
- Sept 2025Strategic agreement with Global Detian Life Sciences Technology (Beijing) for the joint development and manufacture of oncology therapeutics.
- Nov 2025Our Cambridge UK Biopharmaceutical R&D Service Platform is presented at the Dinghu High-Level Talent programme overseas session.
- Dec 2025The platform is approved as a pioneer talent initiative, securing more than £1 million in funding to establish our base in Linping District, Hangzhou.
- 2026 onwardsTwo-phase implementation of the platform with local partners in Hangzhou.
Working in China?
Contact us in English or Chinese. We will reply from the right part of the team.